Dynamic expression of cell-surface antigens probed with Candida albicans-specific monoclonal antibodies

N Deslauriers1, J Michaud1, B Carré1

  • 1Immunology Laboratory, Groupe de Recherche en Ecologie Buccale (GREB), Faculty of Dental Medicine, Université Laval, Québec G1K 7P4, Canada.

Insights

Candida albicans switches between yeast and hyphal forms, altering its surface antigens. Researchers tracked these dynamic antigen changes using monoclonal antibodies (mAbs) to understand fungal development.

Area of Science:

  • Mycology
  • Immunology
  • Cell Biology

Background:

  • Candida albicans exhibits dimorphism, existing as yeast or hyphal forms.
  • Cell-surface antigens play a role in fungal morphology and host interactions.

Purpose of the Study:

  • To investigate the dynamic expression of Candida albicans cell-surface antigens during yeast-to-hyphal transition.
  • To characterize phase-specific antigens using monoclonal antibodies (mAbs).

Main Methods:

  • Production of IgG hybridomas and monoclonal antibodies (mAbs) against C. albicans yeast and hyphal antigens.
  • Immunostaining to analyze antigen expression during different growth phases and hyphal induction.
  • Immunoblot analysis to determine the proteinaceous nature and molecular weight of antigens.

Main Results:

  • Yeast antigens (5C11, 2E11) are expressed during yeast growth and early hyphal stages, while hyphal antigens (2G8, 4E1) appear later on longer hyphae.
  • Galactose-induced hyphal growth alters antigen expression timing and synchronicity.
  • Antigens are proteinaceous, with distinct molecular weights for yeast (68-104 kDa) and hyphal (104-117 kDa) forms.

Conclusions:

  • Candida albicans displays a dynamic balance in phase-specific cell-surface antigen expression.
  • Antigen expression is influenced by growth conditions (glucose vs. galactose) and morphology.
  • Distinct protein profiles characterize yeast and hyphal surface antigens.